for the SPRINT Study Group Women sustaining myocardial infarction fare worse than men during hospitalization. Reports on long-term survival in women surviving an acute myocardial infarction are controversial. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) registry includes 5,839 consecutive myocardial infarction patients who were hospitalized in 13 coronary care units in Israel between 1981 and 1983. The authors examined sex differences in the long-term survival of 4,808 hospital survivors (1,120 women and 3,688 men). Women exhibited a significantly poorer long-term survival than men. After age adjustment, differences between men and women decreased, leaving a survival probability difference of 11 % at the end of 12 years of follow-up. In a subgroup analysis, women exhibited poorer survival than men in a comparison of patients with and without periinfarction congestive heart failure or a history of myocardial infarction preceding the index infarction. The multivariate adjusted hazard ratios associated with female sex in diabetic and nondiabetic patients were 1.46 and 1.13, respectively. In conclusion, a cumulative survival disadvantage for women in comparison with men is still evident after 12 years of follow-up. The mortality difference is diminished but not erased after age adjustment or multivariate adjustment for confounders. The authors' results are compatible with a hypothesis that the main factor underlying the increased long-term mortality in women after myocardial infarction, besides older age, is diabetes mellitus. Am J Epidemiol 1997;146:153-60. myocardial infarction; sex; survival A number of studies (1-3) have shown that women sustaining myocardial infarction fare worse than men during hospitalization. Whether a sex difference exists in the long-term survival of patients after myocardial infarction, beyond the differences in the distribution of risk factors and disease severity, is controversial. Several studies reported poorer long-term survival in women (2, 4, 5), whereas others reported no differences (6-8) or even poorer survival for men (9-11). Some studies have adjusted for age alone, and others have adjusted for age and clinical risk factors. Numerous reasons have been suggested to explain these divergent results, including low power due to the small number of women included in some of the studies (5), differences in the characteristics of men and women with coronary heart disease (12), and different adjustment procedures (13). The long-term follow-up of a large cohort of consecutive cases of patients having
Women sustaining myocardial infarction fare worse than men during hospitalization. Reports on long-term survival in women surviving an acute myocardial infarction are controversial. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) registry includes 5,839 consecutive myocardial infarction patients who were hospitalized in 13 coronary care units in Israel between 1981 and 1983. The authors examined sex differences in the long-term survival of 4,808 hospital survivors (1,120 women and 3,688 men). Women exhibited a significantly poorer long-term survival than men. After age adjustment, differences between men and women decreased, leaving a survival probability difference of 11 % at the end of 12 years of follow-up. In a subgroup analysis, women exhibited poorer survival than men in a comparison of patients with and without periinfarction congestive heart failure or a history of myocardial infarction preceding the index infarction. The multivariate adjusted hazard ratios associated with female sex in diabetic and nondiabetic patients were 1.46 and 1.13, respectively. In conclusion, a cumulative survival disadvantage for women in comparison with men is still evident after 12 years of follow-up. The mortality difference is diminished but not erased after age adjustment or multivariate adjustment for confounders. The authors' results are compatible with a hypothesis that the main factor underlying the increased long-term mortality in women after myocardial infarction, besides older age, is diabetes mellitus. Am J Epidemiol 1997;146:153-60. myocardial infarction; sex; survival A number of studies (1) (2) (3) have shown that women sustaining myocardial infarction fare worse than men during hospitalization. Whether a sex difference exists in the long-term survival of patients after myocardial infarction, beyond the differences in the distribution of risk factors and disease severity, is controversial. Several studies reported poorer long-term survival in women (2, 4, 5) , whereas others reported no differences (6) (7) (8) or even poorer survival for men (9) (10) (11) . Some studies have adjusted for age alone, and others have adjusted for age and clinical risk factors. Numerous reasons have been suggested to explain these divergent results, including low power due to the small number of women included in some of the studies (5), differences in the characteristics of men and women with coronary heart disease (12) , and different adjustment procedures (13) . The long-term follow-up of a large cohort of consecutive cases of patients having sustained myocardial infarctions offered an opportunity to examine sex differences in long-term prognosis after acute myocardial infarction. The rate and risk factors for mortality in hospital and mortality 1 year after discharge among 5,839 consecutive myocardial infarction patients have been reported (3) . We now report results of 12 years of follow-up in 1,120 female myocardial infarction survivors after their discharge from hospital and compare them with 3,688 male patients.
MATERIALS AND METHODS
From July 1981 to August 1983, 5,839 consecutive myocardial infarction patients were hospitalized in 13 of 21 coronary care units operating at the time in Israel. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) registry contains data on preinfarction characteristics and hospital course of all of these patients. Medical history and demographic and medical data were collected during hospitalization and 1 year after discharge for all registered myocardial infarction patients. The diagnosis of acute myocardial infarction was established on the basis of the presence of one of three sets of conditions: typical symptoms lasting at least 30 minutes, elevated serum levels of cardiac enzymes, and electrocardiographic findings 154 Benderiy et al. (14) . A total of 322 women (29 percent) and 1,816 men (49 percent) who were found eligible were included in the SPRINT study (14) . One thousand thirtyone patients (404 women and 627 men) died during hospitalization. The remaining 4,808 patients (1,120 women and 3,688 men) were followed up for mortality over a mean time of 12.1 years (range 11.2-13.3 years). Follow-up time until death or October 1994 (analysis cutoff date) ranged between 1 day and 13.3 years (mean 8.1 years). Periinfarction congestive heart failure was identified on the basis of at least one of the following: pulmonary congestion, pulmonary edema, or cardiogenic shock either on admission or during hospitalization in the coronary care unit.
Mortality
Vital status was ascertained through October 1994 from the Israeli population registry for 4,739 hospital survivors (data were missing for 69 patients of whom at least 39 were tourists or nonpermanent Israeli residents). Follow-up was thus complete for 98.6 percent of patients. The underlying cause of death was coded according to the International Classification of Diseases, Ninth Revision, with information obtained from death certificates. The cause of death could not be determined for 77 patients.
Statistical analysis
Data were analyzed using SAS software (15, 16) , unless otherwise stated. Rates in table 1 were adjusted for age using the direct method, with the combined population of men and women as the standard population. Age-specific mortality rates per 1,000 personyears in men and women and the rate ratios of mortality (table 3) for the age groups younger than 50, 50-59, 60-69, and 70 or more years were computed using the RATES2 program included in the Computer Programs for Epidemiologic Analysis collection (17) . An overall rate ratio was obtained using the RATES2 program, pooling rates over the above-mentioned age groups.
Actuarial survival curves were computed using the LIFETEST procedure. Time was calculated from hospital discharge until death or end of follow-up. The log rank test was used to compare survival curves for men and women. Age-adjusted, sex-specific survival curves for patients with and without history of myocardial infarction, diabetes, or periinfarction congestive heart failure (figure 2) were obtained using a direct adjustment method (18) .
Age-and multivariate-adjusted analyses of mortality for men and women were performed using the Cox proportional hazard method (PHREG procedure) to account for differing lengths of follow-up and correlations with covariables. The validity of proportional hazards associated with female sex over time was tested by running a model including sex and a timedependent explanatory variable and testing the null hypothesis (/3 = 0) (16) , where /3 is the regression parameter for the time-dependent variable. The p value for rejecting the null hypothesis when, in fact, relative hazards were proportional was 0.17.
RESULTS

Preinfarction characteristics, hospital course, and therapy
Women discharged from hospital after acute myocardial infarction were, on average, 6 years older than men (table 1) . Thirty-nine percent of the women and 21 percent of the men were aged 70 years or older at the time of the index myocardial infarction. A larger percentage of women reported history of hypertension and diabetes compared with men (table 1). However, with the exception of angina pectoris, prior manifestations of disease such as peripheral vascular disease and history of myocardial infarction (preceding the index myocardial infarction) were more frequent among men. In addition, the prevalence of smoking, at baseline, was higher among men than among women. These differences persisted after age adjustment. A smaller proportion of women suffered from arrhythmias during hospitalization, but women were more likely to have experienced complications such as cardiac arrest, atrioventricular block, and periinfarction congestive heart failure (differences were not statistically significant).
At discharge, a greater proportion of women were prescribed nitrates compared with men (50 vs. 44 percent, respectively), and the same held true with respect to digitalis (17 vs. 12 percent) and treatment for diabetes mellitus (14 vs. 7 percent).
Mortality among hospital survivors
During 12 years of follow-up, 1,912 (52 percent) men and 731 (65 percent) women died. The distribution of the causes of death was similar in men and women (table 2). Ischemic heart disease was recorded as the underlying cause of death in about half of the patients (52 and 51 percent of women and men who died, respectively). Age-specific all-cause mortality rates (per 1,000 person-years) were only slightly higher in women in all age groups except for those aged 50-54 and 65-69 years (p for comparison of rates pooled over age groups = 0.08) (table 3). In the latter age groups, mortality risks in women were 0.97 and 0.91 times the risks in men, respectively. The
Long-term Prognosis of Women after Myocardia) Infarction female to male rate ratio of mortality was highest in patients aged 80 years or older (rate ratio = 1.55, 95 percent confidence interval (CI) 1.10-2.19). A similar pattern was observed for coronary heart disease mortality.
Survival analysis. The 12-year survival of 4,739 hospital survivors by sex is presented in figure 1 . Women exhibited a significantly poorer long-term survival than men (p for differences between curves = 0.0001). The cumulative probabilities of mortality at the end of 12 years of follow-up were 0.52 for men and 0.67 for women. After adjustment for age (figure 1), differences between men and women decreased and the curves ran parallel from the second year on. At the end of 12 years of follow-up, age-adjusted mortality risk in women was 11 percent greater than in men. When multivariate adjustment was applied, the 12-year cumulative mortality probabilities were 0.60 and 0.55 for women and men, respectively. Examination of survival by periinfarction congestive heart failure, either on admission to the coronary care unit or during the course of hospitalization, showed a disadvantage for women both among patients who sustained periinfarction congestive heart failure and in patients free of congestive heart failure (figure 2, c). Women with a history of myocardial infarction preceding the index infarction (figure 2, a) exhibited poorer age-adjusted survival than their male counterparts. The 12-year survival rates were 0.23 for women and 0.32 for men. The rates in patients for whom the index myocardial infarction was the first infarction were 0.43 and 0.49 for women and men, respectively. As shown in figure 2b, there were no substantial differences in survival between nondiabetic men and nondiabetic women, with only a slight disadvantage for women over the follow-up period (12-year cumulative probabilities of survival were 0.45 and 0.47 for women and men, respectively). Conversely, among diabetics, from the 156 Benderty et al. • Rate ratio for mortality pooled over age strata, t CHD, coronary heart disease. beginning of follow-up, women had a significantly lower survival rate than diabetic men (0.26 and 0.34, respectively). Multivahate analysis. Female sex was associated with a 20 percent increase of mortality risk after adjustment for age (entered as a continuous variable), history of myocardial infarction, preinfarction angina pectoris, hypertension, diabetes, peripheral vascular disease, renal failure, pulmonary disease, cerebrovascular accident, smoking, periinfarction congestive heart failure, increased serum level of lactate dehydrogenase, and myocardial infarction location (table 4) . Data for all of these variables were available for 84 percent of the patients (881 women and 3,142 men) who were included in the final analysis. In addition to the above-mentioned variables, participation in the SPRINT study was also included to adjust for possible confounding by participation in the trial during the first year of follow-up. When a model was applied only to the 2,670 patients who were not included in the SPRINT clinical trial, the results were identical to those obtained for all of the patients (hazard ratio associated with the female sex = 1.19, 95 percent CI 1.05-1.34). A multivariate analysis restricted to the 900 women and 2,795 men for whom the index myocardial infarction was the first myocardial infarction yielded similar results. The hazard ratio associated with female sex was 1.15 (95 percent CI 1.02-1.29).
Because the results of the bivariate survival analysis indicated an interaction between sex and diabetes, we repeated the analysis separately for diabetic and nondiabetic patients. Nondiabetic women had an estimated increased mortality risk of slightly more than 10 percent compared with nondiabetic men (hazard ratio = 1.13, 95 percent CI 1.00-1.27). The adjusted 
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DISCUSSION
Previous studies of the long-term prognosis of women after myocardial infarction have yielded conflicting results; however, most of those studies included fewer than 500 women due to age limits imposed as exclusion criteria or the small samples studied. The large cohort of women in the SPRINT registry who were hospitalized for acute myocardial infarction in the early 1980s, before the advent of thrombolysis, exhibited higher case fatality rates than their male counterparts during hospitalization and 1 year after the index myocardial infarction (3). A greater early mortality risk for women in comparison with men was found in the majority of the studies comparing the fate of men and women after myocardial infarction (1,2) . The present 12-year follow-up of a large cohort provided an opportunity to compare the long-term survival of men and women after acute myocardial infarction. Our main finding was that the early disadvantage in the prognosis of women compared with men is still evident after 12 years of followup.
All previous reports comparing men and women who had survived a myocardial infarction identified differences in the baseline characteristics between the two sexes. In our study, female hospital survivors experienced the index myocardial infarction at an older age and exhibited a less favorable clinical condition than men. This was expressed primarily by hypertension and diabetes, which preceded the index myocardial infarction more frequently in women than in men. Can these differences, noted at the time of the index myocardial infarction, fully account for the observed differences in the long-term survival of men and women? Goldberg et al. (11) reported on the largest group of women followed after myocardial infarction, a multihospital community study of 1,232 women and 1,916 men hospitalized for acute myocardial infarction in six time periods. In accordance with our results, they found greater crude long-term mortality in women than in men. A considerable portion of the difference in survival between men and women in our cohort could be explained by the older age of women sustaining myocardial infarction, as demonstrated by age adjustment. In other studies, malefemale survival differences after myocardial infarction were fully accounted for by age differences (8, 11) . In another study, Johansson et al. (7) did not find a difference in long-term survival among 1,259 men and 262 women surviving a first infarction in Goteborg, Sweden, with the only exception being poorer survival in women younger than 45 years. A higher risk for men was also reported after adjustment for multiple risk factors (11) .
We observed a similar age-adjusted survival of nondiabetic men and women, in contrast to the considerably poorer survival of diabetic women compared with diabetic men. This finding reflects a strong interaction between sex and diabetes. The interaction appeared to be more pronounced in patients surviving more than one myocardial infarction. It is not clear why diabetes affects men and women differently or why this should differ between survivors of single and multiple infarctions. A larger infarction size was suggested as a possible explanation (19) for short-term excess mortality in diabetic patients reported after myocardial infarction in both men and women (20, 21) . Stone et al. (22) reported that diabetic women developed a smaller infarct and yet experienced an almost twofold increase in cardiac mortality compared with men or nondiabetic women during a mean follow-up time of 34.9 months. The combination of diabetes and hypertension is common among women sustaining myocardial infarction and is frequently accompanied by diabetic nephropathy, which exposes them to a higher mortality rate (23) . Congestive heart failure and recurrent myocardial infarction were also reported to be more frequent among diabetic women than among diabetic men (24) . In addition, diabetic dyslipidemia, characterized by an alteration of lipoprotein composition and by decreased levels of high density lipoprotein cholesterol and increased levels of very low density lipoprotein cholesterol, has been shown to be more pronounced among diabetic women than among men or nondiabetic women (25) . However, not all reports are in agreement. In contrast to our results, Abbud el al. (20) observed that diabetes exerted a similar long-term (3 years) risk on men and women aged 50-69 and 70-89 and a greater risk for men in the age group 30-49 years. In another report, Weinblatt et al. (9) reported similar mortality among
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Periinfarction congestive heart failure or more than one myocardial infarction did not appear to reinforce the increased mortality among women in our study. When we analyzed age-adjusted survival, we noted poorer survival in women with and without a history of myocardial infarction (preceding the index myocardial infarction) or periinfarction congestive heart failure. Further adjusting survival for additional risk factors using the Cox proportional hazard model had only a minor effect on our results.
Additional variables not considered in the SPRINT registry, such as hemostatic and biochemical factors, also may have contributed to the poorer survival of women. For example, plasma fibrinogen, which is associated with the development of atherosclerotic plaques and thrombus formation, has been shown to be higher in women, both in patients with coronary heart disease (26) and in men and women free of the disease (27) .
It remains to be understood why different populations appear to show diverse effects of myocardial infarction on the prognosis of men and women. Differences between reports on long-term prognosis of women compared with men may reflect intercountry variation. International comparisons reveal a major variation of male to female mortality ratios between countries (28) . As a result, we can see differences in life expectancies of men and women between countries. In 1990, the life expectancies at age 65 in Israel compared with the United States were 15.8 versus 15.2 for men and 17.7 versus 19.3 for women (29) . Such opposite directions with respect to sex may explain why we have found higher mortality among women after infarction than did American studies. Varying sex differences in prognosis after myocardial infarction may contribute to the aforementioned life expectancy differences between countries.
Our cohort represents one of the largest reported groups of consecutive cases of female patients having sustained myocardial infarctions. Several limitations of the data should, however, be noted. Because longterm follow-up was limited to vital status, we do not have information on nonfatal incidence of recurrent myocardial infarction or coronary procedures beyond the first year of follow-up. Differences between men and women in the incidence rate of recurrent nonfatal myocardial infarction may affect the differences in the long-term mortality of the two sexes. However, Marrugat et al. (4) did not find differences in reinfarction rate between men and women who suffered a transmural infarction during a mean follow-up time of 5 years. Treatment changes may have occurred and been implemented in the patients included in the SPRINT registry. These may have been dictated by changes in disease severity or by new approaches to the treatment of coronary heart disease patients. During the follow-up period, thrombolytic therapy and percutaneous transluminal coronary angioplasty were introduced. Additional changes in the treatment of coronary heart disease patients have occurred, including increased use of /3 blockers and aspirin as well as the introduction of angiotensin-converting enzyme inhibitors as the treatment of choice in heart failure. In addition, emergency coronary artery bypass surgery was implemented.
In conclusion, we have shown a prognostic disadvantage for women after acute myocardial infarction in comparison with men, which is evident in excess mortality with a decreasing mortality risk over time. A cumulative increased risk associated with female sex remained after 12 years of follow-up and was apparent in most age groups. The mortality difference between men and women is diminished but not erased after multivariate adjustment for confounders. The results are compatible with a hypothesis that the main factor underlying the increased long-term mortality in women after myocardial infarction, besides older age, is diabetes mellitus. This hypothesis, if true, requires independent confirmation and an understanding of the underlying mechanism. Diabetic patients with acute myocardial infarction differ in several important respects from nondiabetic counterparts, and it remains to be understood which of these differences are particularly deleterious in women and why. This knowledge will carry clinical significance for the management and treatment of women surviving myocardial infarction.
